TABLE 6D - INVALID PROCEDURE CODES
Procedure Code	Description	O.R.	MDC	MS-DRG
0X6L0Z2^	Detachment at Right Thumb, Mid, Open Approach	Y	05	255, 256, 257
""			08	513, 514
""			09	579, 580, 581
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	906
""			24	957, 958, 959
""				981, 982, 983
0X6M0Z2^	Detachment at Left Thumb, Mid, Open Approach	Y	05	255, 256, 257
""			08	513, 514
""			09	579, 580, 581
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	906
""			24	957, 958, 959
""				981, 982, 983
0Y6P0Z2^	Detachment at Right 1st Toe, Mid, Open Approach	Y	01	040, 041, 042
""			05	255, 256, 257
""			08	503, 504, 505
""			09	579, 580, 581
""			10	616, 617, 618
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
0Y6Q0Z2^	Detachment at Left 1st Toe, Mid, Open Approach	Y	01	040, 041, 042
""			05	255, 256, 257
""			08	503, 504, 505
""			09	579, 580, 581
""			10	616, 617, 618
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
GZB1ZZZ^	Electroconvulsive Therapy, Unilateral-Multiple Seizure	N		
GZB3ZZZ^	Electroconvulsive Therapy, Bilateral-Multiple Seizure	N		
X27H385*	Dilation of Right Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	04	166, 167, 168
""			05	252, 253, 254
""			06	356, 357, 358
""			07	423, 424, 425
""			08	515, 516, 517
""			09	579, 580, 581
""			10	628, 629, 630
""			11	673, 674, 675
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X27H395*	Dilation of Right Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	04	166, 167, 168
""			05	252, 253, 254
""			06	356, 357, 358
""			07	423, 424, 425
""			08	515, 516, 517
""			09	579, 580, 581
""			10	628, 629, 630
""			11	673, 674, 675
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X27H3B5*	Dilation of Right Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	04	166, 167, 168
""			05	252, 253, 254
""			06	356, 357, 358
""			07	423, 424, 425
""			08	515, 516, 517
""			09	579, 580, 581
""			10	628, 629, 630
""			11	673, 674, 675
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X27H3C5*	Dilation of Right Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	04	166, 167, 168
""			05	252, 253, 254
""			06	356, 357, 358
""			07	423, 424, 425
""			08	515, 516, 517
""			09	579, 580, 581
""			10	628, 629, 630
""			11	673, 674, 675
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X27J385*	Dilation of Left Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	04	166, 167, 168
""			05	252, 253, 254
""			06	356, 357, 358
""			07	423, 424, 425
""			08	515, 516, 517
""			09	579, 580, 581
""			10	628, 629, 630
""			11	673, 674, 675
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X27J395*	Dilation of Left Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	04	166, 167, 168
""			05	252, 253, 254
""			06	356, 357, 358
""			07	423, 424, 425
""			08	515, 516, 517
""			09	579, 580, 581
""			10	628, 629, 630
""			11	673, 674, 675
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X27J3B5*	Dilation of Left Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	04	166, 167, 168
""			05	252, 253, 254
""			06	356, 357, 358
""			07	423, 424, 425
""			08	515, 516, 517
""			09	579, 580, 581
""			10	628, 629, 630
""			11	673, 674, 675
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X27J3C5*	Dilation of Left Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	04	166, 167, 168
""			05	252, 253, 254
""			06	356, 357, 358
""			07	423, 424, 425
""			08	515, 516, 517
""			09	579, 580, 581
""			10	628, 629, 630
""			11	673, 674, 675
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""			21	907, 908, 909
""			24	957, 958, 959
""				981, 982, 983
X27K385*	Dilation of Proximal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27K395*	Dilation of Proximal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27K3B5*	Dilation of Proximal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27K3C5*	Dilation of Proximal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27L385*	Dilation of Proximal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27L395*	Dilation of Proximal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27L3B5*	Dilation of Proximal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27L3C5*	Dilation of Proximal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27M385*	Dilation of Distal Right Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27M395*	Dilation of Distal Right Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27M3B5*	Dilation of Distal Right Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27M3C5*	Dilation of Distal Right Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27N385*	Dilation of Distal Left Popliteal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27N395*	Dilation of Distal Left Popliteal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27N3B5*	Dilation of Distal Left Popliteal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27N3C5*	Dilation of Distal Left Popliteal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27P385*	Dilation of Right Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27P395*	Dilation of Right Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27P3B5*	Dilation of Right Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27P3C5*	Dilation of Right Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27Q385*	Dilation of Left Anterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27Q395*	Dilation of Left Anterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27Q3B5*	Dilation of Left Anterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27Q3C5*	Dilation of Left Anterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27R385*	Dilation of Right Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27R395*	Dilation of Right Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27R3B5*	Dilation of Right Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27R3C5*	Dilation of Right Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27S385*	Dilation of Left Posterior Tibial Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27S395*	Dilation of Left Posterior Tibial Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27S3B5*	Dilation of Left Posterior Tibial Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27S3C5*	Dilation of Left Posterior Tibial Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27T385*	Dilation of Right Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27T395*	Dilation of Right Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27T3B5*	Dilation of Right Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27T3C5*	Dilation of Right Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27U385*	Dilation of Left Peroneal Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27U395*	Dilation of Left Peroneal Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27U3B5*	Dilation of Left Peroneal Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
X27U3C5*	Dilation of Left Peroneal Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5	Y	05	252, 253, 254
""			14	769, 817, 818, 819
""			17	823, 824, 825, 829, 830, 850
""			18	853, 854, 855, 856, 857, 858
""			19	876
""				981, 982, 983
XW033K5*	Introduction of Fosfomycin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5	N		
XW033N5*	Introduction of Meropenem-vaborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5	N		
XW033U5*	Introduction of Imipenem-cilastatin-relebactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 5	N		
XW043K5*	Introduction of Fosfomycin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5	N		
XW043N5*	Introduction of Meropenem-vaborbactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5	N		
XW043U5*	Introduction of Imipenem-cilastatin-relebactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5	N		
XW097M5*	Introduction of Esketamine Hydrochloride into Nose, Via Natural or Artificial Opening, New Technology Group 5	N		
XW0DXJ5*	Introduction of Apalutamide Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5	N		
XW0DXL5*	Introduction of Erdafitinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5	N		
XW0DXR5*	Introduction of Venetoclax Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5	N		
XW0DXT5*	Introduction of Ruxolitinib into Mouth and Pharynx, External Approach, New Technology Group 5	N		
XW0DXV5*	Introduction of Gilteritinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 5	N		
XXE5XM5*	Measurement of Infection, Whole Blood Nucleic Acid-base Microbial Detection, New Technology Group 5	N		

	Notes:
	(*)-These codes were discussed at the March 19, 2024 - March 20, 2024 ICD-10 Coordination and Maintenance Committee meeting and were not finalized in time to include in the proposed rule. They will be invalid effective October 1, 2024.
	(^)-These codes were invalid effective April 1, 2024.
